Its part coaching platform, part prescription conveyor - and part behavioural experiment
dose reduction required if eGFR 3044 ml/min/1.73m Rybelsus (semaglutide) prescribing criteria are more restrictive: Licensed for type 2 diabetes management, not for weight loss as a standalone indication NICE NG28 recommends GLP-1 receptor agonists as an option for adults with type 2 diabetes when: For weight management specifically , a different formulation of semaglutide (Wegovy, subcutaneous injection) has been approved by NICE (TA875) for adults with: BMI 35 kg/m (or 32.5 kg/m in people of South Asian, Chinese, Black African, or Black Caribbean ethnicity) or BMI 3034.9 kg/m (or 27.5 kg/m in people from the above ethnic groups) with at least one weight-related comorbidity And participation in a specialist weight management service Access to Wegovy is subject to local commissioning arrangements and availability through specialist weight management services, as outlined in NICE TA875

You can try using an app or a log to keep track of how much water youre drinking, or carry a large, refillable bottle with you throughout your day, as a few strategies to keep hydration from falling under the radar
During this initial appointment, our clinical team will evaluate your physical and metabolic vitals, including: Cardiovascular & Blood Volume Baseline: Reviewing active blood pressure, heart rate, and metabolic vitals to ensure total safety before prescribing advanced peptide or GLP-1 therapies
Calorie Intake & Food Choices Think about the daily extras: sauces, sugary coffees, fried snacks grabbed in a hurry